Contact this trialFirst, we need to learn more about you.
Chemotherapy Agent
Venetoclax + Tagraxofusp-erzs + Chemotherapy for BPDCN
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying how well venetoclax, SL-401, and chemotherapy work in treating patients with blastic plasmacytoid dendritic cell neoplasm.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.